Fund Details
FL
Forge Life Science Partners
10th Floor 110 Cannon Street, London, EC4N 6EU, United Kingdom
Overview
Investment portfolio
7rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Khartis Therapeutics | Aug 2026Led | $50 MSeries B | |
Infinimmune | Aug 2026Participated | $75 MSeries A | |
Kinaset Therapeutics | Jan 2026Led | $103 MSeries B | |
Idrx | Aug 2024Participated | $120 MSeries B | |
OnCusp Therapeutics | Jan 2024Participated | $100 MSeries A | |
Escient Pharmaceuticals | Nov 2022Led | $120 MSeries C | |
Idrx | Aug 2022Participated | $122 MSeries A | |
Khartis Therapeutics | Aug 2026Led | $50 MSeries B | |
Infinimmune | Aug 2026Participated | $75 MSeries A | |
Kinaset Therapeutics | Jan 2026Led | $103 MSeries B | |
Idrx | Aug 2024Participated | $120 MSeries B | |
OnCusp Therapeutics | Jan 2024Participated | $100 MSeries A | |
Escient Pharmaceuticals | Nov 2022Led | $120 MSeries C | |
Idrx | Aug 2022Participated | $122 MSeries A |
7 Items
7
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 3 |
| Series B | 2 | 1 |
| Series C+ | 1 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Aug '22 | 1 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 1 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 2 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 7 |
| Consumer & Lifestyle | 3 |
| AI & Machine Learning | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 0 |
| $50M-$100M | 2 |
| $100M-$250M | 5 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 7 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Nextech Invest | 3 |
| RA Capital Management | 3 |
| 5AM Ventures | 2 |
| Andreessen Horowitz | 2 |
| Casdin Capital | 2 |
| Merck | 2 |
| Abingworth | 1 |
| Alexandria Venture Investments | 1 |
| Altitude Life Science Ventures | 1 |
| Atlas Venture | 1 |
| Avego Bioscience Capital | 1 |
| Blackbird BioVentures | 1 |
| Blackstone | 1 |
| Catalio Capital Management | 1 |
| Civilization Ventures | 1 |
| CJNV BioVenture | 1 |
| Commodore Capital | 1 |
| Cowen Healthcare Investments | 1 |
| EQT Life Sciences (LSP) | 1 |
| Everbright Biofund | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 3 | 43% |
| Participating | 4 | 57% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 33% |
| Co-led | 2 | 67% |